Latest News in the pharma Industry

Top Stories

Enanta Signs License Agreement with Novartis

Enanta Signs License Agreement with Novartis

22 Feb 2012

Novartis will be responsible for all costs associated with the development, manufacture and commercialization of EDP-239 and will fund Enanta's drug discovery efforts on certain additional compounds targeting NS5A.

Read more 
Sigma Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio

Sigma Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio

22 Feb 2012

Sigma Life Science has acquired a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio.

Read more 
Johnson & Johnson Names Alex Gorsky CEO Effective April 26, 2012

Johnson & Johnson Names Alex Gorsky CEO Effective April 26, 2012

22 Feb 2012

Mr. Gorsky succeeds Bill Weldon, who has served as Chairman and CEO of Johnson & Johnson since 2002.

Read more 
DPT Laboratories Appoints R&D VP

DPT Laboratories Appoints R&D VP

22 Feb 2012

Dr. Bhatia will lead the research and pharmaceutical development group and oversee DPT's Center of Excellence for R&D in San Antonio.

Read more 
Brenntag Launches New Head Office in India

Brenntag Launches New Head Office in India

21 Feb 2012

The German chemicals distributor's new head office will provide room for the firm’s planned growth in India over the next few years.

Read more 
Pfizer Considers $3Bn Partial IPO

Pfizer Considers $3Bn Partial IPO

21 Feb 2012

Pfizer is said to raise about $3bn this year through a part-flotation of its animal health division.

Read more 
18% Growth in Sales Accelerates Investment and Expansion Plans for Robinson Brothers and Endeavour

18% Growth in Sales Accelerates Investment and Expansion Plans for Robinson Brothers and Endeavour

20 Feb 2012

UK’s independent chemical manufacturer Robinson Brothers Limited announced a significant rise in group sales for 2011.

Read more 
Endeavour Speciality Chemicals Enters Partnership with AKL Research

Endeavour Speciality Chemicals Enters Partnership with AKL Research

20 Feb 2012

Under the agreement Endeavour will act as the sole scale-up partner for the AKL range of building blocks and chemical intermediates, many of which are commercially novel.

Read more 
Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals

Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals

20 Feb 2012

Par Pharmaceutical has completed the acquisition of India-based Edict Pharmaceuticals, a developer and manufacturer of generic pharmaceuticals with 11 ANDAs filed with the FDA.

Read more 
Evotec & IR Pharma Ink Respiratory Discovery Pact

Evotec & IR Pharma Ink Respiratory Discovery Pact

17 Feb 2012

Under the alliance, Evotec will offer fully integrated respiratory and inflammation focused drug discovery programs, from target to nomination of preclinical development candidates.

Read more 
Actavis Launches Donepezil in Eight EU Markets

Actavis Launches Donepezil in Eight EU Markets

17 Feb 2012

The conventional tablets were launched in Germany, France, Italy, Spain, the UK, Denmark, Sweden and Austria this week.

Read more 
GSK Withdraws Application for Tyverb Indication Extension

GSK Withdraws Application for Tyverb Indication Extension

17 Feb 2012

The decision to withdraw the application was based on the CHMP’s assessment that the lack of an active-controlled trial hampers the proper assessment of the benefit-risk balance in European patients in the applied indication.

Read more